CoMind
London-based DeepTech company developing non-invasive brain monitoring systems and AI clinical analytics, using neurophotonics to measure cerebral perfusion, autoregulation and intracranial pressure at the bedside.
CoMind is a DeepTech company based in London, founded in 2018, that develops non-invasive brain monitoring solutions built on neurophotonics and artificial intelligence. Its stated aim is to measure and treat brain health without invasive procedures, with a focus on optimising patient outcomes across the care continuum from diagnosis through treatment and recovery.
Its flagship product, CoMind One, is a non-invasive brain monitoring system designed for bedside use. It provides clinicians with real-time insight into neurophysiological parameters, including cerebral perfusion, autoregulation and intracranial pressure, drawing on photonics and AI algorithms rather than invasive measurement. Alongside it sits CoVision, an AI-powered analytics platform that generates predictive clinical insights intended to support patient safety, healthcare economics and clinical outcomes.
The company operates across healthcare settings including intensive care units, surgical theatres, emergency medicine and neurology. Technical work spans photonics, non-invasive brain monitoring, machine learning, predictive clinical analytics and medical devices. The company was founded by James Dacombe, who was 17 years old at the time of founding.